Variant histologic features can emerge in therapy-resistant prostate cancers, with treatment-emergent small-cell neuroendocrine carcinomas (t-SCNC) the most common. Here we report clinical, histopathological, and genomic features of 126 t-SCNCs and 14 other treatment-emergent variant histologies. This retrospective mul...
Nadeem Bilani, Jesenia M. Perez, Ana M. Aparicio et al.· Cancer Research Communicatio...· 0 citations
A deep learning model that leverages interpretable cellular features to improve feature extraction from H&E-stained tissue sections (NEURAL-PC) and represents an extensively validated diagnostic and prognostic model for advanced prostate cancer.
Zhi-Jun Chen, Erolcan Sayar, D. Guevara et al.· JCI Insight· 0 citations
It is shown that metastasis-to-metastasis seeding is the dominant pattern of cancer spread and that increased polyclonal migration predicts poor prognosis, and that post-mortem cell-free DNA captures genomic and transcriptional heterogeneity of the subtypes, which provides a potential strategy for noninvasive assessmen...
P. Itagi, Samantha L. Schuster, Sonali Arora et al.· Nature· 0 citations
A pro-tumorigenic IL-1β/IL-6 signaling circuit mediated through local macrophages and fibroblasts is identified that unleashes the full oncogenic potential of a cancer driver activated at the PIN stage, with implications for TME-specific targeted therapeutics in early-stage disease.
Young-Sun Lee, Jimmy L. Zhao, Agnieszka Chryplewicz et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
